Aragen Life Sciences is exhibiting at the EFMC conference in Booth #62 on September 6-10 to discuss targeted protein degrader programs and integrated drug discovery strategies.
Public source
Publisher name
Public post
Advancing a Targeted Protein Degrader (TPD) program or navigating complex medicinal chemistry challenges? Visit Aragen at EFMC Booth #62 (Sep 6-10) to discuss complex ch…
Company
Aragen Life Sciences
- Industry
- Pharmaceutical Manufacturing
- Location
- Hyderabad, IN
- Company size
- 1,001–5,000 employees
About Aragen Life Sciences
Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement. At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.
See moreLatest activity
Latest activity from Aragen Life Sciences
9 signals
Presence & Recognition
Aragen Life Sciences is exhibiting at Booth #422 during Discovery on Target 2026
Presence & Recognition
Aragen Life Sciences is hosting its experts at EuroTox 2026 in Vienna from September 13 to 16, 2026.
Presence & Recognition
Aragen Life Sciences discovery experts will be at Booth #62 at the EFMC conference in Basel, Switzerland for the next three days.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Piramal Pharma Solutions
Piramal Pharma Solutions is exhibiting at Booth 104 at the Chem Outsourcing conference in Boston from September 15-17, 2026, to discuss integrated CDMO capabilities and program development.
Presence & Recognition
BioDuro
BioDuro is attending the 7th edition of the Fragment-Based Drug Discovery Meeting in Cambridge from September 14-16.
Presence & Recognition
Syngene International Limited
Syngene International Limited's experts Anjan, Nhakulan, and Shilpi are attending the IPSC Target Validation and CRISPR Activity event at Booth 504 in Boston from September 28 to October 1, 2026.
Presence & Recognition
Ami Lifesciences Pvt. Ltd.
Ami Lifesciences Pvt. Ltd. is attending the Fiera Milano event from 6 to 8 October 2026 to showcase its capabilities across APIs, HPAPIs, end-to-end CDMO solutions, Deuteroedge deuterated chemistry, and small-chain peptides.
Presence & Recognition
WuXi Discovery Services